Though not as safe a bet as safe-haven assets like precious metals, value stocks are nonetheless an enticing option for investors when the market gets bumpy. An undervalued company that has excellent fundamentals but a less-than-stellar recent stock performance history is often better positioned to benefit during periods of volatility than growth names with less of a track record of success.

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=131709&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your The Trade Desk, Inc. (NASDAQ:TTD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-trade-desk-inc-lawsuit-submission-form?prid=131711&wire=1 or contact Joseph E. Levi, Esq.

SAN DIEGO , Feb. 24, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group, Inc. (NASDAQ: TMDX) publicly traded securities between February 28, 2023 and January 10, 2025, all dates inclusive (the "Class Period"), have until April 15, 2025 to seek appointment as lead plaintiff of the TransMedics class action lawsuit. Captioned Jewik v.

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your Constellation Brands, Inc. (NYSE:STZ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/constellation-brands-inc-lawsuit-submission-form?prid=131708&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your Newmont Corporation (NYSE:NEM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/newmont-corporation-lawsuit-submission-form?prid=131712&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=131710&wire=1 or contact Joseph E. Levi, Esq.

A stock's dividend yield is a key metric to consider when shopping for long-term, sustainable income picks. Dividend payments are a delicate dance for investors; offering a dividend that's too high could put the future of the company at risk while cutting dividends too severely could put off long-term investors.

WALTHAM, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 10:30 a.m. ET.

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Grocery Outlet Holding Corp. ("Grocery Outlet" or "the Company") (NASDAQ:GO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Grocery Outlet securities between November 7, 2023 and May 7, 2024, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Grocery Outlet Holding Corp. ("Grocery Outlet" or "the Company") (NASDAQ:GO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Grocery Outlet securities between November 7, 2023 and May 7, 2024, both dates inclusive (the "Class Period").

-- TrialNet to conduct the Phase 2 randomized, placebo-controlled clinical study -- SAN FRANCISCO and NEW YORK , Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) and TrialNet, an international clinical trial network at the forefront of diabetes research, today announced a new collaboration agreement to evaluate Nektar's rezpegaldesleukin in patients with new onset stage 3 type 1 diabetes mellitus (T1D). Rezpegaldesleukin is a novel agonistic T regulatory (Treg) cell biologic that is designed to both dampen the inflammatory response and simultaneously restore immune balance by directly expanding functional Treg cells and engaging multiple immunoregulatory pathways.

SAN FRANCISCO , Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that it will host a virtual investor and analyst event with Type 1 Diabetes (T1D) Experts on Monday, February 24, 2025 at 3:00 p.m. EST / 12:00 p.m.

VANCOUVER, BC , Feb. 24, 2025 /PRNewswire/ -- Siyata Mobile Inc. (Nasdaq: SYTA) ("Siyata" or the "Company"), a global vendor of Push-to-Talk over Cellular ("PoC") devices and cellular signal booster systems, today announced a new distribution agreement with IP Access International, a leading provider of reliable communication solutions for organizations operating in challenging environments. Through this partnership, IP Access International will offer Siyata's SD7 rugged PoC devices and accessories to its extensive customer base, which includes fire departments, mining operations, oil and energy companies, utilities, and other industries that require robust, mission-critical communication solutions in remote areas.

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ModivCare, Inc. ("ModivCare" or "the Company") (NASDAQ:MODV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ModivCare securities between November 3, 2022 and September 15, 2024, both dates inclusive (the "Class Period").

Fourth Quarter Revenue Increase of 25% year-on-year, Highest Growth Rate Since Going Public, Full Year Revenue Increase of 17% 20th Consecutive Quarter of Record Transactions, Strengthening Digital Freight Leadership BARCELONA, Spain , Feb. 24, 2025 /PRNewswire/ -- Freightos Limited (NASDAQ: CRGO), the leading vendor-neutral digital booking and payment platform for the international freight industry, today reported financial results for the quarter and year ended December 31, 2024. "Freightos continues to lead the digital transformation of global freight, delivering in the fourth quarter our highest revenue growth rate since going public, our strongest carrier expansion ever, and record gross profit margin," …

NEW YORK , Feb. 24, 2025 /PRNewswire/ -- Vestar Capital Partners, a leading U.S. middle-market private equity firm, announced today it has completed the sale of Simple Mills (or "the Company"), a premium brand of better-for-you crackers, cookies, snack bars, and baking mixes, to Flowers Foods, Inc. (NYSE: FLO) for a total enterprise value of $795 million. Vestar provided the first institutional investment into the brand in October 2019, and was the Company's largest shareholder.

REHOVOT, Israel , Feb. 24, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or "CollPlant", a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced the expansion of its distribution channels for its Vergenix™ STR product, in Europe and Asia. VergenixSTR is based on the Company's rhCollagen technology and is intended for the treatment of tendinopathy by promoting healing and repair of tendon injuries in a variety of tendons including the elbow tendon (for treatment of "tennis elbow"), rotator cuffs, patellar tendons, the Achilles tendon, and hand …

WASHINGTON , Feb. 24, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article entitled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S" in Molecular Therapy Nucleic Acids1, a Cell Press partner journal, that describes the development of a novel antisense oligonucleotide (ASO) therapeutic, VCA-894A, for a patient with a rare variant in the IGHMBP2 gene causing Charcot-Marie-Tooth disease Type 2S (CMT2S). In 1886, Jean-Martin Charcot, Pierre Marie, and Henry Tooth independently described this hereditary motor and sensory neuropathy in their patients, paving the way for Charcot-Marie-Tooth (CMT) disease research.2,3 It was not …

VANCOUVER, BC , Feb. 24, 2025 /PRNewswire/ - New Found Gold Corp. ("New Found" or the "Company") (TSXV: NFG) (NYSE-A: NFGC) is pleased to announce new drill results from the Company's 100%-owned Queensway Gold Project ("Queensway") in Newfoundland and Labrador, Canada. Highlights include: Golden Dome Zone ("Golden Dome"): 148 g/t Au over 4.10m 1 and 41.3 g/t Au over 2.40m (NFGC-24-2188); and 22.4 g/t Au over 2.00m (NFGC-24-2199).